|
MESSAGE FROM THE DIRECTOR
|
 Stan Gerson, MD
Director, Case Comprehensive Cancer Center
|
Change in Administrative Leadership
Dear members of the Case Comprehensive Cancer Center community:
I want to update you on a change in leadership within
 |
|
|
Megan Kilbane, MBA |
Cancer Center administration. At the end of this month
Megan Kilbane, MBA will be stepping down as Associate Director for Administration to take a position at the Cleveland Clinic Taussig Cancer Institute. In her new role as Senior Administrator for Cancer Research, Megan will oversee multiple research projects, both basic and clinical, and will continue to foster collaboration between institutions.
Megan was hired by the Case CCC as Assistant Dean for Oncology, Strategic Development, and Chief of Staff to the Director in January 2015. She was appointed Associate Director for Administration in October 2016. She stewarded the organization to our Exceptional rating review by the National Cancer Institute in 2017, an accomplishment that has been met with national acclaim. She has reorganized and expanded the administrative team into an effective, Case CCC member-responsive organization.
The cancer center will hold a national search for the Associate Director for Administration. We will send out the posting as soon as it is approved by human resources.
In the meantime, we are grateful to have a very
|
|
|
John Pounardjian, MBA
|
accomplished administrator to move into the role ofActing Associate Director for Administration.
John Pounardjian, MBA was named Deputy Associate Director of Administration in March 2017. He has been a member of the Case CCC administration team since 2012, previously serving as GI SPORE Administrator.
Please join me in wishing Megan the best of luck in her new role. We are confident she will continue to steward the mission of the Case CCC at Taussig. Congratulate John on taking on the role, while you help him keep the center vibrant.
|
CWRU School of Medicine Selected for STAT Madness Bracket
The Case Western Reserve School of Medicine was
named 1 of 64 teams to compete in
STAT madness, a bracket-style tournament to find the best innovations in science and medicine from institutions across the country. Thank you to all who cast votes for the project, "Cancer Test You Can Swallow" led by Case CCC members
Sandy Markowitz, MD, PhD and
Amitabh Chak, MD, MS! The match-up in round one was a tight race that unfortunately did not push the innovative project to round two.
|
Majhail Appointed President of American Society for Transplantation and Cellular Therapy (formerly ASBMT)
The Case Comprehensive Cancer Center extends congratulations to Navneet Majhail, MD, MS  for his recent appointment to President of the American Society for Transplantation and Cellular Therapy (ASTCT), formerly known as the American Society for Blood and Marrow Transplantation (ASMBT).
Majhail is Director of the Blood and Marrow Transplant Program at the Cleveland Clinic and a member of the Case CCC's Hematopoietic and Immune Cancer Biology Program. |
Gilligan to Speak at NCCN Annual Conference
The National Comprehensive Cancer Network  will host more than 1,500 cancer care professionals at its annual conference in Orlando, Florida from March 21-23, 2019.
Case Comprehensive Cancer Center member  Timothy Gilligan, MD, MS will present, "Staging of Testicular Cancer: Germ Cell Tumors" on Friday, March 22 at 3:25pm. Read more about this years' conference highlights and focus> |
Cancer Center Seminar Series: "Metabolic Regulation of Melanoma Metastasis"
Mar 8, 12p | WRB Auditorium
Join us today at noon in the Wolstein Research
 Building Auditorium to hear
Sean Morrison, PhD present, "Metabolic Regulation of Melanoma Metastasis." Dr. Morrison is Director of the Children's Medical Center Research Institute, the Kathryne and Gene Bishope Distinguished Chair in Pediatric Research and Mary McDermott Cook Chair in Pediatric Genetics at The University of Texas Southwestern Medical Center.
The Seminar Series
will
be
available to view via live stream. While we highly encourage you to attend in person to interact with our speakers and receive CME credit, we understand that may not always be possible. Presentations will not be recorded for later viewing, but you may watch the seminar in real time and ask questions via chat.
Watch live at noon>
|
Biomedical Innovation & Entrepreneur Club
Mar 20, 4-6p | BRB 932
Case Western Reserve University is home to a
 new entrepreneurship club, meeting the third Wednesday of every month! Graduate students, medical students and post-docs are welcome to attend.
Curious to know how the licensing process works for commercializing a product or therapeutic? As a student, what is your share of the intellectual property? Please bring your questions to the next meeting with Stephanie Weidenbecher, MBA, MS and Wayne Hawthorne, MBA from the CWRU Tech Transfer Office.
Please contact
cvmp@case.edu with any questions.
|
Save $10 on GvHD Symposium Registration
April 26, 2019 | Cleveland Airport Marriott
Annual Graft
vs. Host Disease Symposium to take place Friday, April 26 at the Cleveland Airport Marriott. Use code
CANCERCENTER
to save $10 on your registration.
This unique conference, which focuses on cutting edge research and new treatments, consists of two tracks: one designed for physicians and other health care professionals, and one for bone marrow transplant (BMT) survivors, their families and their caregivers.
more>
|
CANCER CENTER PROFILE: CLINICAL TRIAL
|
Can a Swallowable Capsule Revolutionize Screening for Esophageal Cancer?
An NIH-funded, multi-center clinical trial underway at University Hospitals (UH) is aimed at improving outcomes for patients with Barrett's Esophagus (BE) and esophageal cancer. The outcome of this cancer remains poor, accounting for over one in 50 adult male cancer-related deaths. UH gastroenterologist and
Case CCC member
Amitabh Chak, MD is looking to change this state of affairs through this clinical trial.
Barrett's esophagus, a precursor of esophageal cancer, can be easily recognized at endoscopy; however, current clinical strategies of endoscopic screening and surveillance based on the close association of BE with chronic gastroesophageal reflux disease (GERD) in adults are woefully inadequate. Despite endoscopic screening and surveillance efforts, less than 5 percent of esophageal cancers are diagnosed in individuals with previously detected BE.
The study involves 4 groups of patients:
- Adults 18 and older with known BE or esophageal cancer
- Adults between age 40 and 85 who've had heartburn for at least five years and are having esophago-gastro-duodenoscopy (EGD) for evaluation of GERD
- Adults between age 40 and 85 who've had heartburn or taken proton pump inhibitors for at least five years and are referred for a screening colonoscopy
- Adult controls 18 and older who are having an EGD without signs of BE or esophageal cancer
White males are at increased risk of BE and esophogeal cancer, which is reflected in the study's inclusion criteria. In groups 2 and 3, patients must be a white male or meet at least 3 of the following criteria:
- Male gender
- White race
- Obesity (BMI > 30)
- History of smoking
- Family history - two family members with reported BE or esophageal cancer
|
2019 V Foundation V Scholar Cancer Research Grant
Internal Deadline: March 18, 2019
 The Case Comprehensive Cancer Center is invited to nominate one investigator for the
V Foundation's V Scholar Cancer Research Grant Program. The V Scholar Award supports early tenure-track faculty by funding a range of projects from laboratory-
based fundamental research through bench to bedside research. The total amount of the grant is $200,000, paid in two annual installments of $100,000. Only direct costs of the research are supported by this award.
Projects may be focused in ANY area of adult cancer research.
Eligibility:
- US Citizen or permanent legal resident of the US
- Possess at least 2 years post-doctoral fellowship training
- Hold a tenure-track faculty position as assistant professor
- Have been appointed to first full-time assistant professorship within the last 5 years, not yet promoted to associate professor
- NOT already holding an RO1 or RO1-equivalent as PI or co-leader
- NOT already a co-leader on projects such as SPORE or NIH grant mechanisms like U01, DP1, DP2, R37 and R23.
Submit a one-page LOI and biosketch to
casecccpilots@case.edu.
Contact John Pounardjian at 216.368.0846 with any questions.
|
Samuel Waxman Cancer Research Foundation 2019-2021 Cancer Research Awards
Internal Deadline: March 20, 2019
The Case Comprehensive Cancer Center is invited
to nominate one investigator for the
new awards
from the Samuel Waxman Cancer Research Foundation (SWCRF)
.
SWCRF anticipates funding half of the awards for research that will focus on the interplay of aging and cancer; the other half for research that will address aspects of aberrant gene expression, differentiation, or epigenetic therapies that relate to cancer.
8 two-year awards of $100,000 a year are available.
Review the full RFA here.
For consideration, please submit a one-page LOI and biosketch to
casecccpilots@case.edu
by Wednesday, March 20, 2019
.
Contact John Pounardjian at 216.368.0846 with any questions.
|
University Hospitals Funding Opportunities
Deadlines: April 1 & 3, 2019
University Hospitals Seidman Cancer Center has  released a request for applications for pilot projects are requested for new cancer-focused research proposals utilizing "big data"/health informatics in cancer research with a focus on population health, health services research, quality and longitudinal outcomes. Applications are due April 1, 2019. View the full RFP>
University Hospitals Case Medical Center Neurological Institute and Seidman Cancer Center is requesting applications for collaborative pilot projects in support of the new Center of Exellence for Translational Neuro-Oncology (CETNO). The RFA supports both research awards and an infrastructure award available to both UH and CWRU-affiliated investigators. Applications are due April 3, 2019. View the full RFP>
|
Department of Defense (DoD) Funding Opportunities
The office of Congressionally Directed Medical Research Programs recently released the following funding opportunity:
|
15 Questions to Ask Your Doctor About Your Cancer Risk Factors
Prevention - Feb 8, 2019
Experts share important questions to ask your doctor about your cancer risk factors. Cleveland Clinic hematologist oncologist and member of the Case CCC's Developmental Therapeutics Program Smitha Krishnamurthi, MD comments.
Exploradio Origins: The Birth of Cancer Immunotherapy
WKSU - Feb 14, 2019
"Our newest chemotherapies are immune treatments that recognize abnormal cells based on abnormal proteins which result from the abnormal mutations that occurred because of the mismatch repair loss," says Stan Gerson, MD, Director of the Case CCC. |
NIH BULLETIN - Notices and Funding Opportunities
|
|
|
FOLLOW US
|
Have news or updates to share?
Contact our communications team at
|
EVENTS
|
|
Fri, Mar 8
CWRU & UH Rainbow Babies & Children's Hospital Shave It Off 2019
7a-6p UH Rainbow Babies & Children's Hospital Performance Area
Cancer Center Seminar Series
Sean Morrison, PhD
Kathryne and Gene Bishop Distinguished Chair in Pediatric Research Children's Research Institute at UT Southwestern Director, Children's Mary McDermott Cook Chair in Pediatric Genetics
"
Metabolic Regulation of Melanoma Metastasis"
12p WRB Auditorium
|
|
Mon, Mar 11
Shared Resources Directors Meeting
12p WRB 1-422D
Cancer Center Special Seminar
Xiang-Yang (Shawn) Wang, PhD
Professor of Genetics, Immunology and Radiation
Mary Anderson Harrison Distinguished Professor in Cancer Research
Associate Scientific Director, Immunology
VCU Institute of Molecular Medicine
VCU Massey Cancer Center
Virginia Commonwealth University School of Medicine
"Improving Cancer Immune Responsiveness by Lighting a Fire in the Tumor Microenvironment"
12p WRB 2-136
Genomic Medicine Institute Integrative and Translational Seminar Series
David Lemberg, MS, DC
Associate Professor
National University
San Diego, CA
"Ethical, Legal and Social Issues in Genomic Medicine Practice"
12p NE1-205
Wolstein Research Building Faculty Meetings with Stan Gerson
2:30p WRB
|
|
Weds, Mar 13
PRCHN Monthly Seminar
Monica Webb Hooper, PhD
Director, Office of Cancer Disparities Research
Case Comprehensive Cancer Center
"Digital Interventions and African American Tobacco Smokers: Culturally Specific Enhancements"
12p BioEnterprise Building Ground Floor Conference Room
Cancer Center Special Seminar
Mythreye
Karthikeyan,
PhD
Assistant Professor
Department
of Chemistry and Biochemistry
Department
of Drug Discovery and Biomedical Sciences
University
of South Carolina
"Growth Factor Networks in Tumor Progression and
Metastasis"
12p WRB
2-136
Molecular Biology and Microbiology Seminar: Pathogen of the Month
Nga Le
"Cryptosporidium"
1p WRT 206
|
|
Thurs, Mar 14
Developmental Therapeutics Journal Club
9a N
E
6-218
Molecular Biology and Microbiology Seminar
Fredrick Kizito
Kien Nguyen
1p SOM W203
|
|
Fri, Mar 15
Taussig Cancer Institute Grand Rounds
8a CA5-120
Cancer Center Seminar Series
Jason Mears, PhD
Assistant Professor, Pharmacology
Case Western Reserve University
"Mitochondrial Fission: Structure, Function and Cancer Implications"
12p WRB Auditorium
|
|
Mon, Mar 18
CWRU SOM Lunch & Lecture
Christopher Leggett, MD [MED '86]
Interventional Cardiologist and Entrepreneur
12p Robbins Building
Cancer Center Research Chalk Talk
Magdalena Grabowska, PhD
1p WRB 3-136
|
|
Tues, Mar 19
CWRU SOM Faculty Toolkit Session
Promotion & Tenure for Faculty in the Tenure Track
12p BRB 105
Cancer Center Drug Discovery and Resistance
George Stark, PhD
Professor Emeritus, Cancer Biology
CWRU/Cleveland Clinic
3p WRB 1-422D
|
|
Thurs, Mar 21
Developmental Therapeutics Journal Club
9a NE6-218
Molecular Biology and Microbiology Virology Journal Club
RCR+4: Human CRISPR
1p SOM W203
|
|
Fri, Mar 22
Taussig Cancer Institute Grand Rounds
8a CA5-120
Cancer Center Seminar Series
John DiPersio, MD, PhD
Virginia E and Samuel J Goldman Professor of Medicine
Chief, Division of Oncology Deputy Director
Siteman Cancer Center Washington University School of Medicine
"
Optimizing Allogeneic Transplant for the Treatment of Acute Leukemia
"
12p WRB Auditorium
|
ADDITIONAL UPCOMING SYMPOSIUMS & EVENTS
NCCN Annual Conference
March 21-23, 2019
Orlando, FL
Genomic Medicine Institute International PTEN Symposium
April 8, 2019
Intercontinental Hotel & Conference Center
44th Annual ONS Congress
April 11-14, 2019
Anaheim, CA
Dialogue for Action® on Cancer Screening and Prevention
April 24-26, 2019
Arlington, VA
GvHD National Symposium
Apr 26, 2019
Cleveland Airport Marriott
Apr 27-28, 2019
Seattle, WA
Cancer Center Scientific Series: Research Innovation Fund
May 1, 2019 | 8:30a
WRB Auditorium
2019 Great Lakes Breast Cancer Research Symposium
May 2, 2019
Columbus, OH
|
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Deadlines Vary: Mar 12-14, 2019
Deadline: Mar 13, 2019
Deadlines: Mar 14 & Mar 28, 2019
Deadline: Mar 15, 2019
Internal Deadline: Mar 18, 2019
Deadline: Mar 18, 2019
Internal Deadline: Mar 19, 2019
Neuroendocrine Tumor Research Foundation-AACR Grant
Deadline: Mar 19, 2019
Deadlines: Apr 1 & Oct 15, 2019
Foundation for Women's Wellness Research Awards
Deadline: Apr 5, 2019
Deadline: Apr 15, 2019
Deadline: July 24, 2019
Deadline: July 24, 2019
Deadline: July 31, 2019
Deadline: July 31, 2019
Deadline: Open
Case CCC Travel Awards for Trainees
Deadline: Open
Deadline: Open
Deadline: Open
Deadline: Open
Deadline: Open
|
|
 |
|
